The hypotheses surrounding the experiment were that the dobutamine would produce tachycardia and vasodilation and fail to improve the microcirculation of patients with septic shock.
The results of the double-blind test showed that dobutamine increased heart rate, cardiac index and stroke volume index, which increased in 52 percent of the patients. Patient blood pressure remained unchanged but systemic vascular resistance decreased.
More Articles on Anesthesia:
Compounding Pharmacies May Relieve Drug Shortage for Anesthesiologists
Checklist for F1RSTUse Platform Released by Anesthesia Business Consultants
Accutron’s Ultra PC Flowmeter Sedation System Recalled by FDA
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
